Concepedia

Adam Bucki

AB

Statistics

Publications

45

Citations

1.2K

H-Index

23

Active since

2007

Affiliations

Jagiellonian University(Current)

Medicina

Institute of Psychiatry and Neurology

Adamed (Poland)

Maj Institute of Pharmacology

Adam Bucki is an author at Jagiellonian University specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2007–2024

45

Publications

45

Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation

Anna Więckowska, Marcin Kołaczkowski, Adam Bucki et al. · European Journal of Medicinal Chemistry · 2016 · 84 citations · Full text

, , +11

Novel Arylsulfonamide Derivatives with 5-HT<sub>6</sub>/5-HT<sub>7</sub>Receptor Antagonism Targeting Behavioral and Psychological Symptoms of Dementia

Marcin Kołaczkowski, Monika Marcinkowska, Adam Bucki et al. · Journal of Medicinal Chemistry · 2014 · 66 citations · Full text

Ligand-Optimized Homology Models of D<sub>1</sub> and D<sub>2</sub> Dopamine Receptors: Application for Virtual Screening

Marcin Kołaczkowski, Adam Bucki, Marcin Feder et al. · Journal of Chemical Information and Modeling · 2013 · 61 citations · Full text

, , +18

Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease

Anna Więckowska, Tomasz Wichur, Justyna Godyń et al. · ACS Chemical Neuroscience · 2018 · 52 citations · Full text

Novel butanehydrazide derivatives of purine-2,6-dione as dual PDE4/7 inhibitors with potential anti-inflammatory activity: Design, synthesis and biological evaluation

Grażyna Chłoń‐Rzepa, Agnieszka Jankowska, Marietta Ślusarczyk et al. · European Journal of Medicinal Chemistry · 2018 · 46 citations · Full text

, , +9

Rows per page

1–5 of 45